News from the Gottesfeld Lab

Potential Friedreich’s Ataxia Drug Based on Gottesfeld Lab Work Starts Clinical Trials (03/26/12)

CIRM Awards Scripps Research Institute Scientists $3.5 Million (05/09/11)

Team Implicates Wayward DNA-Repair Enzyme in Friedreich's Ataxia (01/08/10)

Potential Friedreich's Ataxia Drug Based on Gottesfeld Lab Work Poised to Start Clinical Trials (05/17/10)

Mechanism for Potential Friedreich's Ataxia Drug Uncovered (09/28/09)